We use our strategic consultancy and transformative digital applications to solve some of the most challenging market access issues facing pharmaceutical and biotechnology companies today.
Global market access
From the US to Asia-Pacific, and across Europe, clients depend on our best-in-class capabilities to optimize access and demonstrate the full value of their innovative products to payers. Our multidisciplinary experts and digital visionaries are shaping the market.
From early-stage development through to successful launch and beyond, our HEOR capabilities provide robust analytics and evidence-based strategic insights to support the value of assets – helping inform what healthcare should be provided, how it should be delivered, and to whom.
Global value engagement
Bringing value to life through compelling, insight-driven, evidence-based strategy and communication that makes the complex simple, engages stakeholders, and ensures the value of your assets stand out from the crowd.
Policy and due diligence
Our team of healthcare policy, regulatory, and legislative experts will guide you through the complexities of all aspects of federal and state healthcare policies and help you prepare for how changes will impact coverage, access, payment, care delivery, and consumer choice.